Literature DB >> 20890304

Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.

K Takayama1, S Tsutsumi, S Katayama, T Okayama, K Horie-Inoue, K Ikeda, T Urano, C Kawazu, A Hasegawa, K Ikeo, T Gojyobori, Y Ouchi, Y Hayashizaki, H Aburatani, S Inoue.   

Abstract

The androgen receptor (AR) is a critical transcriptional factor that contributes to the development and the progression of prostate cancer (PCa) by regulating the transcription of various target genes. Genome-wide screening of androgen target genes provides useful information to understand a global view of AR-mediated gene network in PCa. In this study, we performed 5'-cap analysis of gene expression (CAGE) to determine androgen-regulated transcription start sites (TSSs) and chromatin immunoprecipitation (ChIP) on array (ChIP-chip) analysis to identify AR binding sites (ARBSs) and histone H3 acetylated (AcH3) sites in the human genome. CAGE determined 13 110 distinct, androgen-regulated TSSs (P<0.01), and ChIP-chip analysis identified 2872 androgen-dependent ARBSs (P<1e-5) and 25 945 AcH3 sites (P<1e-4). Both androgen-regulated coding genes and noncoding RNAs, including microRNAs (miRNAs) were determined as androgen target genes. Besides prototypic androgen-regulated TSSs in annotated gene promoter regions, there are many androgen-dependent TSSs that are widely distributed throughout the genome, including those in antisense (AS) direction of RefSeq genes. Several pairs of sense/antisense promoters were newly identified within single RefSeq gene regions. The integration of CAGE and ChIP-chip analyses successfully identified a cluster of androgen-inducible miRNAs, as exemplified by the miR-125b-2 cluster on chromosome 21. Notably, the number of androgen-upregulated genes was larger in LNCaP cells treated with R1881 for 24 h than for 6 h, and the percentage of androgen-upregulated genes accompanied with adjacent ARBSs was also much higher in cells treated with R1881 for 24 h than 6 h. On the basis of the Oncomine database, the majority of androgen-upregulated genes containing adjacent ARBSs and CAGE tag clusters in our study were previously confirmed as androgen target genes in PCa. The integrated high-throughput genome analyses of CAGE and ChIP-chip provide useful information for elucidating the AR-mediated transcriptional network that contributes to the development and progression of PCa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890304     DOI: 10.1038/onc.2010.436

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

Review 1.  Minireview: Long noncoding RNAs: new "links" between gene expression and cellular outcomes in endocrinology.

Authors:  Miao Sun; W Lee Kraus
Journal:  Mol Endocrinol       Date:  2013-07-24

2.  Interrelation of androgen receptor and miR-30a and miR-30a function in ER-, PR-, AR+ MDA-MB-453 breast cancer cells.

Authors:  Shuhua Lyu; Han Liu; Xia Liu; Shan Liu; Yahong Wang; Qi Yu; Yun Niu
Journal:  Oncol Lett       Date:  2017-08-21       Impact factor: 2.967

3.  Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.

Authors:  A Kroiss; S Vincent; M Decaussin-Petrucci; E Meugnier; J Viallet; A Ruffion; F Chalmel; J Samarut; N Allioli
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

4.  Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer.

Authors:  Ken-Ichi Takayama; Takashi Suzuki; Shuichi Tsutsumi; Tetsuya Fujimura; Satoru Takahashi; Yukio Homma; Tomohiko Urano; Hiroyuki Aburatani; Satoshi Inoue
Journal:  Mol Endocrinol       Date:  2014-12

Review 5.  Long non-coding RNAs as regulators of the endocrine system.

Authors:  Marko Knoll; Harvey F Lodish; Lei Sun
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

6.  Antisense now makes sense: dual modulation of androgen-dependent transcription by CTBP1-AS.

Authors:  Ying Ying Sung; Edwin Cheung
Journal:  EMBO J       Date:  2013-05-10       Impact factor: 11.598

7.  Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer.

Authors:  D Ashikari; K Takayama; T Tanaka; Y Suzuki; D Obinata; T Fujimura; T Urano; S Takahashi; S Inoue
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

8.  Androgen receptor splice variant AR3 promotes prostate cancer via modulating expression of autocrine/paracrine factors.

Authors:  Feng Sun; He-ge Chen; Wei Li; Xi Yang; Xin Wang; Richeng Jiang; Zhiyong Guo; Hegang Chen; Jiaoti Huang; Alexander D Borowsky; Yun Qiu
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

9.  TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.

Authors:  Ken-Ichi Takayama; Takashi Suzuki; Tomoaki Tanaka; Tetsuya Fujimura; Satoru Takahashi; Tomohiko Urano; Kazuhiro Ikeda; Satoshi Inoue
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

10.  Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells.

Authors:  Aya Misawa; Ken-Ichi Takayama; Tomohiko Urano; Satoshi Inoue
Journal:  J Biol Chem       Date:  2016-06-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.